In order to be at the forefront of drug discovery, translational and clinical research, PeploBio provides Molecular (qPCR) and Immunoassay (ELISA) development services that ensure actionable insights. Our highly experienced scientific team is well versed in working with novel targets/biomarkers and technologies. Furthermore, we approach each project collaboratively with you, providing weekly progress updates and scientific support.
As an ISO 15189 accredited laboratory, PeploBio provides assay validation services for a wide variety of biomarkers, reagents, and devices. Due to our highly experienced scientific team with expertise in molecular biology, immunology, infectious diseases, biochemistry, metabolism, and oncology, we routinely provide. Bespoke Assay Development services for novel biomarkers. Once the assay performance is considered optimal, we support our sponsors through assay validation and subsequently Phase 1 and 2 clinical trial testing.
Furthermore, PeploBio is highly experienced in working with diagnostic products and partnering with reagent and device manufacturers seeking to receive. UKCA, CE IVD marking or CDTA regulatory approval. Our state-of-the-art QMS and expert team of PhD and HCPC registered scientists ensures that our sponsors have access to the necessary personnel and technologies to support their study throughout its duration, novel targets, biomarkers and technologies. Furthermore, we approach each project collaboratively with you, providing weekly progress updates and scientific support.
